In a recent study published in the journal BMC Medicine , researchers determined the relationship between heavy menstrual bleeding (HMB) or menorrhagia and cardiovascular disease (CVD) in the presence and absence of irregular menstruation (IM) among females hospitalized in the United States (US). Cardiovascular disease is the primary cause of death globally. Given gender disparities and the rising incidence of cardiovascular disease and metabolic syndrome (MS), particularly among females, it is crucial to discover modifiable contributory risk factors for cardiovascular disease prevention in the female population.
Menorrhagia is defined as excessive blood loss during menstruation or clinically excessive menstrual bleeding impairing the physical, mental, and social well-being and life quality of afflicted women. Menorrhagia imposes a significant financial burden on affected individuals regarding treatment expenses and productivity losses. It is also related to anemia, exhaustion, headaches, and discomfort.
The link between menorrhagia and iron deficiency-type anemia may impede oxygen transfer and alter heart function. Study: Association of heavy menstrual bleeding with cardiovascular disease in US female hospitalizations . Image Credit: Emily Frost / Shutterstock In the present retrospective, cross-sectional study, researchers explored the influence of menorrhagia and irregular menstruation on cardiovascular disease risk.
The researchers extracted records of hospitalizations am.
